Flow cytometry has moved from a specialist research tool to core infrastructure for cancer diagnostics, immunotherapy development, and cell-based research. Demand is rising across hospitals, biopharma pipelines, and academic labs. Here is where the market stands, who leads it, and what is driving it. Market Snapshot & Key Metrics According to Grand View Research, the flow cytometry market...